Clinical Trials Browser

Phase 1/2 × Sarcoma, Ewing × anlotinib × Clear all

NCT03416517 2019-02-15

Anlotinib and Irinotecan for Ewing Sarcoma

Phase 1/2 Unknown

Neoplasm Metastasis, Sarcoma, Ewing